Clinical Trials & Research
The faculty of the Hepatology Program are actively engaged in clinical research into novel therapies, improved diagnostic modalities, and better biomarkers and predictors of outcome. All patients seen in any of the Hepatology Clinics who are potential candidates for new therapies and other research protocols are referred for participation in clinical trials.
The faculty play key roles in multiple NIH-sponsored clinical research networks sponsored by the National Institutes of Health (NIH) including
- Acute liver failure
- Biomarkers for early diagnosis of hepatocellular carcinoma.
- Drug-induced liver injury
- Hepatitis B
- Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C)
The program is also involved in many clinical trials supported by pharmaceutical companies that evaluate new therapies for various liver diseases including hepatitis B and C, fatty liver disease, and hepatocellular carcinoma.
